Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Multi-Center, Placebo Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Doses Of NT100 Following IVF In Women With A History Of Repeated IVF Failures (Thrive-IVF)

NCT01864356 is registered in ClinicalTrials.gov with Nora Therapeutics, Inc. as lead sponsor.

NCT NCT01864356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01864356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Multi-Center, Placebo Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Doses Of NT100 Following IVF In Women With A History Of Repeated IVF Failures (Thrive-IVF)
Lead sponsor
Nora Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2014
Enrollment
157 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

repeated ivf failure